6 completed, 3 withdrawn, 1 active not recruiting, 1 enrolling by invitation. 4 Not applicable, 4 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Early Phase 1 | 1 | Withdrawn 1 |
Follow Priapism: new trials by email Literature Review of Priapism trials Research Report on Priapism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Sequestration of Holistic Stress Management Techniques for Adults Holistic Medicine (HM) - Stress, Job, PTSD | Not applicable | Withdrawn | Goddess Zena I. Jones | 2026-01-26 | 2026-02-04 | |
| Investigation of the Protective Effect of Alpha Lipoic Acid on Ischemic Reperfusion Damage in Ischemic Priapism in Rats Ischemic priapism + reperfusion, Ischemic priapism + reperfusion + ALA - Priapism, Reperfusion Injury | Not applicable | Completed | Trabzon Kanuni Education and Research Hospital | 18 | 2024-02-10 | 2026-02-06 |
| Lipid Balance in Adult Sickle Cell Patients HDL2 - Sickle Cell Disease, Dyslipidemia | Not applicable | Active not recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 116 | 2022-11-30 | 2025-12-10 |
| ManAgement of pRiapiSm and Its Impact on Outcomes Priapism | Enrolling by invitation | Policlinic Hospital "G. Rodolico" | 200 | 2021-06-01 | 2025-08-01 | |
| A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism Crizanlizumab - Priapism | Phase 2 | Completed | Novartis Pharmaceuticals | 36 | 2019-10-16 | 2026-01-13 |
| Sleep Study in Adult Patients With Major Sickle Cell Disease With Paroxysmal Nocturnal Events Polysomnography and blood sample - Sickle Cell Disease | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 114 | 2014-09-17 | 2023-05-19 |
| Androgen Regulation of Priapism in Sickle Cell Disease Transdermal Androgel - Priapism, Sickle Cell Disease | Early Phase 1 | Withdrawn | Johns Hopkins University | 2014-03-01 | 2017-01-19 | |
| Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises SelG1, Placebo - Sickle Cell Disease | Phase 2 | Completed | Reprixys Pharmaceutical Corporation | 198 | 2013-07-01 | 2020-01-31 |
| Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia sildenafil, placebo - Sickle Cell Disease, Priapism | Phase 2 | Completed | Johns Hopkins University | 13 | 2008-06-01 | 2017-04-13 |
| Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia tadalafil, placebo - Sickle Cell Anemia, Priapism | Phase 2 | Withdrawn | Johns Hopkins University | 2006-11-01 | 2016-09-21 | |
| Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence Priapism, Anemia, Sickle Cell | Completed | University of Texas Southwestern Medical Center | 1464 | 2005-08-01 | 2019-02-01 |
Anemia, Sickle Cell (9) · Vaso-Occlusive Crises (2) · Anemia (1) · Anxiety Disorders (1) · Arthritis (1) · Arthritis, Rheumatoid (1) · Brain Injuries, Traumatic (1) · Depression (1) · Dyslipidemias (1) · Erectile Dysfunction (1) · Escape Reaction (1) · Fatigue (1) · Flatfoot (1) · Hemorrhoids (1)
Genital Diseases (11) · Genital Diseases, Male (11) · Male Urogenital Diseases (11) · Penile Diseases (11) · Urogenital Diseases (11) · Anemia, Hemolytic (9) · Anemia, Hemolytic, Congenital (9) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Genetic Diseases, Inborn (9) · Hematologic Diseases (9) · Hemic and Lymphatic Diseases (9) · Hemoglobinopathies (9) · Anemia (8) · Cardiovascular Diseases (2) · Endocrine System Diseases (2)
Blood Specimen Collection (1) · Cell Count (1) · Holistic Health (1) · Reperfusion (1) · Sildenafil Citrate (1) · Sugars (1) · Tadalafil (1) · Thioctic Acid (1) · crizanlizumab (1)
Johns Hopkins University (3) · Assistance Publique - Hôpitaux de Paris (1) · Centre Hospitalier Universitaire de la Guadeloupe (1) · Goddess Zena I. Jones (1) · Novartis Pharmaceuticals (1) · Policlinic Hospital "G. Rodolico" (1) · Reprixys Pharmaceutical Corporation (1) · Trabzon Kanuni Education and Research Hospital (1) · University of Texas Southwestern Medical Center (1)
United States (7) · Brazil (1) · France (1) · Guadeloupe (1) · Italy (1) · Jamaica (1) · Portugal (1) · Turkey (Türkiye) (1)
Anoosha Habibi, MD (1) · Arthur L Burnett, MD, MBA (1) · Arthur L. Burnett, MD (1) · Arthur L. Burnett, MD, MBA (1) · Ashok Raj, MD (1) · Cage Johnson, MD (1) · Courtney Thornburg, MD (1) · Cynthia Rutherford, MD (1) · Elliott Vichinsky, MD (1) · Eric Kraut, MD (1) · Giorgio Ivan Russo, MD (1) · J. Bessman, MD (1) · Joan Cain, MD (1) · Karen Kalinyak, MD (1)
PMID 27959701, PMID 36355805, PMID 36529836
R44HL093893 (1), U54HL070587 (1)